《Chinese Journal of Rehabilitation Theory and Practice》 ›› 2022, Vol. 28 ›› Issue (5): 585-592.doi: 10.3969/j.issn.1006-9771.2022.05.014
Previous Articles Next Articles
WEI Juanfang1,WANG Linjie2,CUI Yanru1,CEN Qiuyu1,ZHANG Anren3()
Received:
2021-11-30
Revised:
2022-03-29
Published:
2022-05-25
Online:
2022-06-10
Contact:
ZHANG Anren
E-mail:1518526780@qq.com
Supported by:
CLC Number:
WEI Juanfang,WANG Linjie,CUI Yanru,CEN Qiuyu,ZHANG Anren. Effects of bone marrow mesenchymal stem cells derived exosomes on spinal cord injured animals: a systematic review[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2022, 28(5): 585-592.
"
生物效应 | 作用机制 |
---|---|
促进轴突生长 | 减少硫酸软骨素蛋白聚糖产生,增加生长相关蛋白和神经丝表达,缓解神经传导障碍[ |
促进血管生成 | 上调参与人脐静脉内皮细胞血管生成的关键基因表达,促进血管内皮生长因子、血管生成素等的表达[ |
抗炎 | 促进巨噬细胞M2表型极化,降低炎症因子表达[ |
抗凋亡 | 下调caspase-3/9等表达,增加Bcl-2表达,增强Wnt/β-catenin表达[ |
降低BSCB通透性 | 通过NF-κB p65通路抑制周细胞迁移[ |
"
结局指标 | 评定方法 |
---|---|
运动功能 | ①Basso-Beattie-Bresnahan (BBB)评分。②水平爬梯测试[ |
组织病理学 | ①HE染色。②免疫荧光Hoechst染色[ |
凋亡 | ①TUNEL染色[ |
炎症 | ①炎性因子和抗炎因子表达[ |
轴突生长 | ①免疫荧光染色。②相关基因和蛋白水平[ |
血管生长 | ①血管生成相关因子表达[ |
BSCB通透性 | ①伊文思蓝评估[ |
"
纳入研究 | 动物种属 | 体质量/ 年龄 | n | 节段 | 造模方式 | 干预措施 | 结局指标 | |
---|---|---|---|---|---|---|---|---|
T | C | |||||||
Chang等[ | 雄SD大鼠 | 220~260 g | 72 | T10 | 挫伤:10 g杆12.5 mm高释放 | Ⅰ | PBS | ①②③④ |
Chen等[ | 雄SD大鼠 | 6~8周 | 18 | T10 | 钳夹:75 g夹闭30 s | Ⅱ | PBS | ①②④⑤⑥ |
Gu等[ | 雄SD大鼠 | 220~260 g | 30 | T10 | 挫伤:10 g杆12.5 mm高释放 | Ⅱ | PBS | ①③ |
Huang等[ | 雄SD大鼠 | 180~220 g | 30 | T10 | 挫伤:8 g棒40 mm高释放 | Ⅱ | PBS | ①③④⑦ |
Huang等[ | 雌SD大鼠 | 200~250 g 10周 | 100 | T10 | 挫伤:30 g重物50 mm高释放 | Ⅱ | PBS | ①③④⑤⑧⑨ |
Jia等[ | 雄SD大鼠 | 230~250 g | 40 | T10 | 挫伤:2 N | Ⅱ | 生理盐水 | ①②③ |
Jia等[ | 雄SD大鼠 | 230~250 g | 50 | T10 | 挫伤:2 N | Ⅱ | 生理盐水 | ①②③ |
Li等[ | 雄Wistar大鼠 | 150~200 g | 150 | T9-11 | 挫伤:10 g杆5 cm高释放 | Ⅱ | PBS | ①②③ |
Liu等[ | 雄SD大鼠 | 250~300 g/ 6~8周 | 30 | T9-11 | 挫伤:10 g杆6.5 cm高释放 | Ⅱ | PBS | ①②④ |
Liu等[ | 雄C57BL/6小鼠 | 6~8周 | 56 | T10 | 挫伤:5 g杆6.5 cm高释放 | Ⅱ | PBS | ①②④⑤ |
Liu等[ | 雌SD大鼠 | 170~220 g | 20 | T10 | 挫伤:直径2.5 mm打击器12.5 mm高释放 | Ⅱ | PBS | ①②④ |
Lu等[ | 雄SD大鼠 | 200~250 g | 100 | T10 | 挫伤 | Ⅱ | PBS | ①②③⑩ |
Luo等[ | 雌SD大鼠 | 170~220 g | 40 | T10 | 挫伤:10 g杆12.5 mm高释放 | Ⅱ | PBS | ①②③ |
Yu等[ | 雌SD大鼠 | 230~250 g | 80 | T10 | 挫伤:2 N | Ⅱ | PBS | ①② |
Zhang等[ | 雄SD大鼠 | 200~230 g | 48 | T9 | 挫伤:10 g杆12.5 mm高释放 | Ⅱ | PBS | ①②④ |
Zhao等[ | 雄Wistar大鼠 | 200~250 g | 73 | T10 | 横断:虹膜刀水平切断右侧半圆形脊髓 | Ⅱ | PBS | ①②④? |
Zhou等[ | 雄SD大鼠 | 200~250 g | 160 | T10 | 挫伤:2 N | Ⅱ | PBS | ①②③④⑩ |
董万亮[ | 雄SD大鼠 | 约200 g | 75 | T10 | 挫伤:20 g棒4.5 cm高释放 | Ⅱ | 磷酸盐溶液 | ①? |
裴双等[ | 雄SD大鼠 | 180~200 g | 30 | T10 | 挫伤:2 N | Ⅱ | 磷酸盐溶液 | ①②? |
张锐毅[ | 雄SD大鼠 | 200~250 g | 60 | T10 | 挫伤:2 N | Ⅱ | PBS | ① |
周燕等[ | 雄SD大鼠 | 220~250 g | 80 | T10 | 挫伤:20 kPa | Ⅱ | PBS | ①③④ |
"
纳入研究 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 符合条目 |
---|---|---|---|---|---|---|---|---|---|---|---|
Chang等[ | + | + | 0 | + | 0 | + | 0 | 0 | + | + | 6 |
Chen等[ | + | + | 0 | + | 0 | 0 | + | 0 | + | + | 6 |
Gu等[ | + | + | 0 | + | 0 | 0 | 0 | 0 | + | + | 5 |
Huang等[ | + | + | + | + | 0 | + | + | 0 | + | + | 8 |
Huang等[ | + | + | 0 | + | 0 | 0 | 0 | 0 | + | + | 5 |
Jia等[ | + | + | 0 | + | 0 | + | + | 0 | + | + | 7 |
Jia等[ | + | + | + | + | 0 | + | + | 0 | + | + | 8 |
Li等[ | + | + | + | + | 0 | + | + | 0 | + | + | 8 |
Liu等[ | + | + | 0 | + | 0 | 0 | + | 0 | + | + | 6 |
Liu等[ | + | + | + | + | 0 | + | + | 0 | + | + | 8 |
Liu等[ | + | + | 0 | + | 0 | + | + | 0 | + | + | 7 |
Lu等[ | + | + | + | + | 0 | 0 | + | 0 | + | + | 7 |
Luo等[ | + | + | + | + | 0 | + | + | 0 | + | + | 8 |
Yu等[ | + | + | 0 | + | 0 | 0 | 0 | 0 | + | + | 5 |
Zhang等[ | + | + | + | + | 0 | 0 | + | 0 | + | + | 7 |
Zhao等[ | + | + | + | + | 0 | 0 | + | 0 | + | + | 7 |
Zhou等[ | + | + | 0 | + | 0 | + | 0 | 0 | + | + | 6 |
董万亮[ | + | + | 0 | + | 0 | 0 | 0 | + | + | - | 5 |
裴双等[ | + | + | + | + | 0 | + | + | + | + | + | 9 |
张锐毅[ | + | + | + | + | 0 | + | + | - | + | + | 8 |
周燕等[ | + | + | + | + | 0 | + | + | + | + | + | 9 |
"
结局指标 | n | 方法学局限性 | 相关性 | 结果一致性 | 数据充分性 | 总体评价 |
---|---|---|---|---|---|---|
运动功能 | 21 | 21项研究均存在轻微实施偏倚,9项存在轻微评估偏倚,17项存在轻微报告偏倚,1项存在中度报告偏倚 | 纳入标准与研究问题基本一致 | 均报告运动功能得到改善 | 均进行定量分析,资料充分 | 高 |
组织病理学 | 19 | 19项研究均存在轻微实施偏倚,8项存在轻微评估偏倚,16项存在轻微报告偏倚 | 纳入标准与研究问题基本一致 | 均报告脊髓组织病理得到改善 | 均进行定量或定性分析,资料充分 | 高 |
凋亡 | 11 | 11项研究均存在轻微实施偏倚,3项存在轻微评估偏倚,10项存在轻微报告偏倚 | 纳入标准与研究问题基本一致 | 均报告细胞凋亡得到改善 | 均进行定量或定性分析,资料相对充分 | 中 |
炎症 | 11 | 11项研究均存在轻微实施偏倚,5项存在轻微评估偏倚,10项存在轻微报告偏倚 | 纳入标准与研究问题基本一致 | 均报告炎症得到改善 | 均进行定量或定性分析,资料相对充分 | 中 |
BSCB通透性 | 3 | 3项研究均存在轻微实施偏倚,1项存在轻微评估偏倚,2项存在轻微报告偏倚 | 纳入标准与研究问题一致 | 均报告BSCB渗透性得到改善 | 定性分析,资料不充分 | 低 |
轴突生长 | 1 | 存在轻微的实施、评估和报告偏倚 | 纳入标准与研究问题一致 | 报告轴突生长得到改善 | 定性分析,资料不充分 | 低 |
血管生长 | 1 | 存在轻微的实施和报告偏倚 | 纳入标准与研究问题一致 | 报告血管生长得到改善 | 定性分析,资料不充分 | 低 |
[1] |
ANJUM A, YAZID M D, FAUZI DAUD M, et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms[J]. Int J Mol Sci, 2020, 21(20): 7533.
doi: 10.3390/ijms21207533 |
[2] |
BARNABÉ-HEIDER F, GÖRITZ C, SABELSTRÖM H, et al. Origin of new glial cells in intact and injured adult spinal cord[J]. Cell Stem Cell, 2010, 7(4): 470-482.
doi: 10.1016/j.stem.2010.07.014 |
[3] |
BRADBURY E J, BURNSIDE E R. Moving beyond the glial scar for spinal cord repair[J]. Nat Commun, 2019, 10(1): 3879.
doi: 10.1038/s41467-019-11707-7 |
[4] |
DIAS D O, GÖRITZ C. Fibrotic scarring following lesions to the central nervous system[J]. Matrix Biol, 2018, 68-69: 561-570.
doi: 10.1016/j.matbio.2018.02.009 |
[5] |
ZHOU Y, WEN L L, LI Y F, et al. Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis[J]. Neural Regen Res, 2022, 17(1): 194-202.
doi: 10.4103/1673-5374.314323 |
[6] |
XU H, LEE C W, WANG Y F, et al. The role of paracrine regulation of mesenchymal stem cells in the crosstalk with macrophages in musculoskeletal diseases: a systematic review[J]. Front Bioeng Biotechnol, 2020, 8: 587052.
doi: 10.3389/fbioe.2020.587052 |
[7] |
YUAN X, WU Q, WANG P, et al. Exosomes derived from pericytes improve microcirculation and protect blood-spinal cord barrier after spinal cord injury in mice[J]. Front Neurosci, 2019, 13: 319.
doi: 10.3389/fnins.2019.00319 |
[8] |
REN Z, QI Y, SUN S, et al. Mesenchymal stem cell-derived exosomes: hope for spinal cord injury repair[J]. Stem Cells Dev, 2020, 29(23): 1467-1478.
doi: 10.1089/scd.2020.0133 |
[9] |
LI C, QIN T, ZHAO J, et al. Bone marrow mesenchymal stem cell-derived exosome-educated macrophages promote functional healing after spinal cord injury[J]. Front Cell Neurosci, 2021, 15: 725573.
doi: 10.3389/fncel.2021.725573 |
[10] |
CHANG Q, HAO Y, WANG Y, et al. Bone marrow mesenchymal stem cell-derived exosomal microRNA-125a promotes M2 macrophage polarization in spinal cord injury by downregulating IRF5[J]. Brain Res Bull, 2021, 170: 199-210.
doi: 10.1016/j.brainresbull.2021.02.015 |
[11] |
CHEN Y, TIAN Z, HE L, et al. Exosomes derived from miR-26a-modified MSCs promote axonal regeneration via the PTEN/AKT/mTOR pathway following spinal cord injury[J]. Stem Cell Res Ther, 2021, 12(1): 224.
doi: 10.1186/s13287-021-02282-0 |
[12] |
FAN L, DONG J, HE X, et al. Bone marrow mesenchymal stem cells-derived exosomes reduce apoptosis and inflammatory response during spinal cord injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway[J]. Hum Exp Toxicol, 2021, 40(10): 1612-1623.
doi: 10.1177/09603271211003311 |
[13] |
LIU W, RONG Y, WANG J, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization[J]. J Neuroinflammation, 2020, 17(1): 47.
doi: 10.1186/s12974-020-1726-7 |
[14] |
GU J, JIN Z S, WANG C M, et al. Bone marrow mesenchymal stem cell-derived exosomes improves spinal cord function after injury in rats by activating autophagy[J]. Drug Des Devel Ther, 2020, 14: 1621-1631.
doi: 10.2147/DDDT.S237502 |
[15] |
LUO Y, XU T, LIU W, et al. Exosomes derived from GIT1-overexpressing bone marrow mesenchymal stem cells promote traumatic spinal cord injury recovery in a rat model[J]. Int J Neurosci, 2021, 131(2): 170-182.
doi: 10.1080/00207454.2020.1734598 |
[16] |
LIU W, MA Z, LI J, et al. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury[J]. Stem Cell Res Ther, 2021, 12(1): 102.
doi: 10.1186/s13287-021-02153-8 |
[17] | 张锐毅. 骨髓间充质干细胞来源外泌体对大鼠脊髓损伤后周细胞活化及血脊髓屏障的影响[D]. 郑州: 郑州大学, 2019. |
ZHANG R Y. Effects of exosomes derived from bone marrow mesenchymal stem cells on peripheral cell activation and blood spinal cord barrier after spinal cord injury in rats[D]. Zhengzhou: Zhengzhou University, 2019. | |
[18] |
HUANG J H, XU Y, YIN X M, et al. Exosomes derived from miR-126-modified MSCs promote angiogenesis and neurogenesis and attenuate apoptosis after spinal cord injury in rats[J]. Neuroscience, 2020, 424: 133-145.
doi: 10.1016/j.neuroscience.2019.10.043 |
[19] |
HUANG W, QU M, LI L, et al. SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats[J]. Stem Cell Res Ther, 2021, 12(1): 334.
doi: 10.1186/s13287-021-02401-x |
[20] |
WANG L, PEI S, HAN L, et al. Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NFκB P65 subunit in spinal cord injury[J]. Cell Physiol Biochem, 2018, 50(4): 1535-1559.
doi: 10.1159/000494652 |
[21] |
HUANG J H, YIN X M, XU Y, et al. Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats[J]. J Neurotrauma, 2017, 34(24): 3388-3396.
doi: 10.1089/neu.2017.5063 |
[22] |
LU Y, ZHOU Y, ZHANG R, et al. Bone mesenchymal stem cell-derived extracellular vesicles promote recovery following spinal cord injury via improvement of the integrity of the blood-spinal cord barrier[J]. Front Neurosci, 2019, 13: 209.
doi: 10.3389/fnins.2019.00209 |
[23] |
XIN W, QIANG S, JIANING D, et al. Human bone marrow mesenchymal stem cell-derived exosomes attenuate blood-spinal cord barrier disruption via the TIMP2/MMP pathway after acute spinal cord injury[J]. Mol Neurobiol, 2021, 58(12): 6490-6504.
doi: 10.1007/s12035-021-02565-w |
[24] |
HOOIJMANS C R, ROVERS M M, DE VRIES R B, et al. SYRCLE's risk of bias tool for animal studies[J]. BMC Med Res Methodol, 2014, 14: 43.
doi: 10.1186/1471-2288-14-43 |
[25] |
LEWIN S, BOOTH A, GLENTON C, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series[J]. Implement Sci, 2018, 13(Suppl 1): 2.
doi: 10.1186/s13012-017-0688-3 |
[26] | 陈莉琳, 黄牡丹, 郑海清. 脑卒中后肢体痉挛的识别与评估:Scoping综述[J]. 中国康复理论与实践, 2022, 28(1): 62-68. |
CHEN L L, HUANG M D, ZHENG H Q. Identification and evaluation of post-stroke spasticity: a scoping review[J]. Chin J Rehabil Theory Pract, 2022, 28(1): 62-68. | |
[27] | 王丽群, 庞日朝, 刘建成, 等. 靶向线粒体治疗脊髓损伤的疗效:基于动物实验的系统评价[J]. 中国康复理论与实践, 2021, 27(5): 574-582. |
WANG L Q, PANG R Z, LIU J C, et al. Effect of targeting mitochondria on spinal cord injury: a systematic review based on animal experiments[J]. Chin J Rehabil Theory Pract, 2021, 27(5): 574-582. | |
[28] |
JIA Y, LU T, CHEN Q, et al. Exosomes secreted from sonic hedgehog-modified bone mesenchymal stem cells facilitate the repair of rat spinal cord injuries[J]. Acta Neurochir (Wien), 2021, 163(8): 2297-2306.
doi: 10.1007/s00701-021-04829-9 |
[29] | JIA Y, YANG J, LU T, et al. Repair of spinal cord injury in rats via exosomes from bone mesenchymal stem cells requires sonic hedgehog[J]. Regen Ther, 2021, 18: 309-315. |
[30] |
LI C, JIAO G, WU W, et al. Exosomes from bone marrow mesenchymal stem cells inhibit neuronal apoptosis and promote motor function recovery via the Wnt/β-catenin signaling pathway[J]. Cell Transplant, 2019, 28(11): 1373-1383.
doi: 10.1177/0963689719870999 |
[31] |
LIU J, LIN M, QIAO F, et al. Exosomes derived from lncRNA TCTN2-modified mesenchymal stem cells improve spinal cord injury by miR-329-3 p/IGF1R axis[J]. J Mol Neurosci, 2022, 72(3): 482-495. doi: 10.1007/s12031-021-01914-7. Epub 2021-10-08.
doi: 10.1007/s12031-021-01914-7. Epub |
[32] |
LIU W, WANG Y, GONG F, et al. Exosomes derived from bone mesenchymal stem cells repair traumatic spinal cord injury by suppressing the activation of A1 neurotoxic reactive astrocytes[J]. J Neurotrauma, 2019, 36(3): 469-484.
doi: 10.1089/neu.2018.5835 |
[33] |
YU T, ZHAO C, HOU S, et al. Exosomes secreted from miRNA-29b-modified mesenchymal stem cells repaired spinal cord injury in rats[J]. Braz J Med Biol Res, 2019, 52(12): e8735.
doi: 10.1590/1414-431x20198735 |
[34] |
ZHANG M, WANG L, HUANG S, et al. Exosomes with high level of miR-181c from bone marrow-derived mesenchymal stem cells inhibit inflammation and apoptosis to alleviate spinal cord injury[J]. J Mol Histol, 2021, 52(2): 301-311.
doi: 10.1007/s10735-020-09950-0 |
[35] |
ZHAO C, ZHOU X, QIU J, et al. Exosomes derived from bone marrow mesenchymal stem cells inhibit complement activation in rats with spinal cord injury[J]. Drug Des Devel Ther, 2019, 13: 3693-3704.
doi: 10.2147/DDDT.S209636 |
[36] | 董万亮. 骨髓间充质干细胞来源的外泌体通过TSG-6通路促进脊髓损伤修复的作用及机制研究[D]. 郑州: 郑州大学, 2020. |
DONG W L. The role and mechanism of exosomes derived from bone marrow mesenchymal stem cells in promoting the repair of spinal cord injury through TSG-6 pathway[D]. Zhengzhou: Zhengzhou University, 2020. | |
[37] | 裴双, 王琳, 陈雪梅, 等. 骨髓间充质干细胞来源的外泌体静脉移植对脊髓损伤的修复作用[J]. 中国脊柱脊髓杂志, 2017, 27(12): 1119-1127. |
PEI S, WANG L, CHEN X M, et al. Repair of spinal cord injury by intravenous transplantation of exosomes derived from bone marrow mesenchymal stem cells[J]. Chin J Spine Spinal Cord, 2017, 27(12): 1119-1127. | |
[38] | 周燕, 王琳, 裴双, 等. 骨髓间充质干细胞外泌体可减少脊髓损伤后A1型星形胶质细胞的活化[J]. 中国组织工程研究, 2019, 23(21): 3294-3301. |
ZHOU Y, WANG L, PEI S, et al. Bone marrow mesenchymal stem cell-derived exosomes reduce the activation of type A1 astrocytes after spinal cord injury[J]. ChinJ Tiss Eng Res, 2019, 23(21): 3294-3301. | |
[39] |
H RASHED M, BAYRAKTAR E, K HELAL G, et al. Exosomes: from garbage bins to promising therapeutic targets[J]. Int J Mol Sci, 2017, 18(3): 538.
doi: 10.3390/ijms18030538 |
[40] |
YANG C, GUO W B, ZHANG W S, et al. Comprehensive proteomics analysis of exosomes derived from human seminal plasma[J]. Andrology, 2017, 5(5): 1007-1015.
doi: 10.1111/andr.12412 |
[41] | ZHANG D, LEE H, ZHU Z, et al. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo[J]. Am J Physiol Lung Cell Mol Physiol, 2017, 312(1): L110-L121. |
[42] |
DOMENIS R, CIFÙ A, QUAGLIA S, et al. Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes[J]. Sci Rep, 2018, 8(1): 13325.
doi: 10.1038/s41598-018-31707-9 |
[43] |
HU G W, LI Q, NIU X, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice[J]. Stem Cell Res Ther, 2015, 6(1): 10.
doi: 10.1186/scrt546 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|